[
  {
    "ts": "2025-07-14T08:01:00+00:00",
    "headline": "Amyotrophic Lateral Sclerosis (ALS) Market Analysis Report 2025-2035 | Increase in Clinical Trials and Investments will Accelerate the Development of Innovative Treatments",
    "summary": "The ALS market is witnessing robust growth driven by increased disease awareness, advancements in genetic research, and an expanding pipeline of therapeutic drugs. ALS, a neurodegenerative disease affecting motor neurons, is transitioning from symptomatic treatment to targeted therapies, including gene and disease-modifying therapies. North America leads this market due to strong healthcare infrastructure and investments. Key challenges include high treatment costs and limited awareness in emerg",
    "url": "https://finance.yahoo.com/news/amyotrophic-lateral-sclerosis-als-market-080100838.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "8e158194-589f-3c81-8e8b-66c2de288287",
      "content": {
        "id": "8e158194-589f-3c81-8e8b-66c2de288287",
        "contentType": "STORY",
        "title": "Amyotrophic Lateral Sclerosis (ALS) Market Analysis Report 2025-2035 | Increase in Clinical Trials and Investments will Accelerate the Development of Innovative Treatments",
        "description": "",
        "summary": "The ALS market is witnessing robust growth driven by increased disease awareness, advancements in genetic research, and an expanding pipeline of therapeutic drugs. ALS, a neurodegenerative disease affecting motor neurons, is transitioning from symptomatic treatment to targeted therapies, including gene and disease-modifying therapies. North America leads this market due to strong healthcare infrastructure and investments. Key challenges include high treatment costs and limited awareness in emerg",
        "pubDate": "2025-07-14T08:01:00Z",
        "displayTime": "2025-07-14T08:01:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc",
          "originalWidth": 480,
          "originalHeight": 58,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_MlAqEncKPaKK77zrkRGmQ--~B/aD01ODt3PTQ4MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc.cf.webp",
              "width": 480,
              "height": 58,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/caWFqk489OEmv3xI33JamQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/amyotrophic-lateral-sclerosis-als-market-080100838.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amyotrophic-lateral-sclerosis-als-market-080100838.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BIIB"
            },
            {
              "symbol": "IONS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]